Correction: End-to-End Approach to Surfactant Selection, Risk Mitigation, and Control Strategies for Protein-Based Therapeutics(vol 25, 6, 2023)

Annette Medina Morales; Alavattam Sreedhara; Jakob Buecheler; Sebastian Brosig; Danny Chou; Twinkle Christian; Tapan Das; Isabella de Jong; Jonas Fast; Bharat Jagannathan; Ehab M. M. Moussa; M. Reza Nejadnik; Indira Prajapati; Allison Radwick; Yusra Rahman; Shubhadra Singh

doi:10.1208/s12248-023-00780-y

Back

Correction: End-to-End Approach to Surfactant Selection, Risk Mitigation, and Control Strategies for Protein-Based Therapeutics(vol 25, 6, 2023)

Journal article

Open access

Peer reviewed

Correction: End-to-End Approach to Surfactant Selection, Risk Mitigation, and Control Strategies for Protein-Based Therapeutics(vol 25, 6, 2023)

Annette Medina Morales, Alavattam Sreedhara, Jakob Buecheler, Sebastian Brosig, Danny Chou, Twinkle Christian, Tapan Das, Isabella de Jong, Jonas Fast, Bharat Jagannathan, …

The AAPS journal, Vol.25(1), pp.15-15

01/11/2023

DOI: 10.1208/s12248-023-00780-y

PMID: 36631711

Files and links (1)

url

https://doi.org/10.1208/s12248-023-00780-yView

Published (Version of record) Open Access

Abstract

The original article has been updated to correct the order of authors.

Life Sciences & Biomedicine

Pharmacology & Pharmacy

Science & Technology

Details

Title: Subtitle: Correction: End-to-End Approach to Surfactant Selection, Risk Mitigation, and Control Strategies for Protein-Based Therapeutics(vol 25, 6, 2023)
Creators: Annette Medina Morales - AstraZeneca
Alavattam Sreedhara - Genentech, Pharmaceutical Development, South San Francisco, CA, 94080, USA.
Jakob Buecheler - Novartis
Sebastian Brosig - Novartis
Danny Chou - Compass
Twinkle Christian - Amgen
Tapan Das - Bristol-Myers Squibb
Isabella de Jong - Genentech, Pharmaceutical Development, South San Francisco, CA, 94080, USA.
Jonas Fast - Roche
Bharat Jagannathan - Amgen
Ehab M. M. Moussa - AbbVie
M. Reza Nejadnik - University of Iowa
Indira Prajapati - AstraZeneca
Allison Radwick - Symbiotix Biotherapies
Yusra Rahman - University of Iowa
Shubhadra Singh - GlaxoSmithKline
Resource Type: Journal article
Publication Details: The AAPS journal, Vol.25(1), pp.15-15
Publisher: Springer Nature
DOI: 10.1208/s12248-023-00780-y
PMID: 36631711
ISSN: 1550-7416
eISSN: 1550-7416
Number of pages: 1
Language: English
Date published: 01/11/2023
Academic Unit: Roy J. Carver Department of Biomedical Engineering; Pharmaceutical Sciences and Experimental Therapeutics
Record Identifier: 9984420942102771

Metrics

4 Record Views

1 Times Cited - Web of Science